Search

Your search keyword '"Samuels A"' showing total 3,332 results

Search Constraints

Start Over You searched for: Author "Samuels A" Remove constraint Author: "Samuels A" Topic humans Remove constraint Topic: humans
3,332 results on '"Samuels A"'

Search Results

1. Insurance-Based Disparities in Stroke Center Access in California: A Network Science Approach.

2. Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium.

3. Behavioral Health Decision Support Systems and User Interface Design in the Emergency Department.

4. Outcome class imbalance and rare events: An underappreciated complication for overdose risk prediction modeling.

5. Prevalence and correlates of lifetime suicide attempt in obsessive-compulsive disorder with major depression.

6. Identifying problematic opioid use in electronic health record data: Are we looking in the right place?

7. Topical therapy for regression and melanoma prevention of congenital giant nevi.

8. Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program

9. Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration.

10. Discordances between pediatric and adult thresholds in the diagnosis of hypertension in adolescents with CKD

11. Two data-driven approaches to identifying the spectrum of problematic opioid use: A pilot study within a chronic pain cohort

12. Interim Analysis of Attrition Rates in Palliative Care Study on Dignity Therapy

13. Higher CSF Ferritin Heavy-Chain (Fth1) and Transferrin Predict Better Neurocognitive Performance in People with HIV

14. Mitochondrial DNA haplogroups and domain-specific neurocognitive performance in adults with HIV

15. Is Persistent Motor or Vocal Tic Disorder a Milder Form of Tourette Syndrome?

16. Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4.

17. Melanoma models for the next generation of therapies

18. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation

19. Rational Design of CYP3A4 Inhibitors: A One-Atom Linker Elongation in Ritonavir-Like Compounds Leads to a Marked Improvement in the Binding Strength

20. Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda

21. Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV

22. FaceBase 3: analytical tools and FAIR resources for craniofacial and dental research.

23. MutEx: a multifaceted gateway for exploring integrative pan-cancer genomic data.

24. General personality dimensions, impairment and treatment response in obsessive–compulsive disorder

25. An increase in side-group hydrophobicity largely improves the potency of ritonavir-like inhibitors of CYP3A4

26. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee

27. Trichotillomania comorbidity in a sample enriched for familial obsessive-compulsive disorder

28. Immune-Related Comorbidities in Childhood-Onset Obsessive Compulsive Disorder: Lifetime Prevalence in the Obsessive Compulsive Disorder Collaborative Genetics Association Study

29. Nuclear-Mitochondrial interactions influence susceptibility to HIV-associated neurocognitive impairment.

30. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

31. Structure-Activity Relationships of Rationally Designed Ritonavir Analogues: Impact of Side-Group Stereochemistry, Headgroup Spacing, and Backbone Composition on the Interaction with CYP3A4.

32. Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection

33. Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.

34. The African Descent and Glaucoma Evaluation Study (ADAGES) III Contribution of Genotype to Glaucoma Phenotype in African Americans: Study Design and Baseline Data

35. Genetic Architecture of Primary Open-Angle Glaucoma in Individuals of African Descent The African Descent and Glaucoma Evaluation Study III

36. A cross-species approach to disorders affecting brain and behaviour

37. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.

38. Neurocognitive Function in Children with Primary Hypertension after Initiation of Antihypertensive Therapy

39. Inhibition of Human CYP3A4 by Rationally Designed Ritonavir-Like Compounds: Impact and Interplay of the Side Group Functionalities.

40. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults

41. Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.

42. Genome‐wide association study of HIV‐associated neurocognitive disorder (HAND): A CHARTER group study

43. An investigation of doubt in obsessive–compulsive disorder

44. Parental bonding and hoarding in obsessive–compulsive disorder

45. Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.

46. Neurocognitive Function in Children with Primary Hypertension

47. Thyroid Function Variations Within the Reference Range Do Not Affect Quality of Life, Mood, or Cognitive Function in Community-Dwelling Older Men.

48. Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation.

49. Whole-genome association analysis of treatment response in obsessive-compulsive disorder.

50. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY)

Catalog

Books, media, physical & digital resources